News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
24 Oct 2024
byStephen Padilla
Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.
24 Oct 2024








